Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis

DOI: 10.1634/theoncologist.2018-0114

Keywords: Decision support techniques, Pancreatic neoplasms, Cost‐benefit analysis, Computer simulation

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text